There were 148 press releases posted in the last 24 hours and 440,188 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Mustang Bio Announces Upcoming Presentations of Clinical Data from Phase 1/2 Trial of MB-106, a CD20-Targeted Autologous CAR T Cell Therapy

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image